The following table details the trading activities
(stock purchases, stock sales, and stock option exercises)
the Securities and Exchange Commission (SEC)
by insider Brynjelsen Sean since year 2005.
The trader's CIK number is 1669976.
At the time of the last reporting, Brynjelsen Sean was the President & CEO of Eton Pharmaceuticals, Inc. .
(stock ticker symbol ETON).
See this page for all insider trading activities at Eton Pharmaceuticals, Inc. .
|Trade Date||Symbol||Company Name (Issuer)||Trade Type||Shares||Price ($)||Value ($)|
|2019-08-13||ETON||Eton Pharmaceuticals, Inc.||Buy||5,000||6.15||30,750|
|2019-05-21||ETON||Eton Pharmaceuticals, Inc.||Buy||8,600||7.96||68,430|
|2019-05-20||ETON||Eton Pharmaceuticals, Inc.||Buy||1,400||7.78||10,894|
|2018-11-15||ETON||Eton Pharmaceuticals, Inc.||Buy||10,000||6.00||60,000|
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Brynjelsen Sean (President & CEO of Eton Pharmaceuticals, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.